XML 37 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings per Share ("EPS"): (Tables)
3 Months Ended
Mar. 31, 2014
Earnings Per Share [Abstract]  
Reconciliation of numerator and denominator used in computation of earnings per share
The following table reconciles the numerator and denominator used in the computation of earnings per share for the three months ended March 31, 2014 and 2013 (shares in thousands):
 
 
For the Three Months Ended March 31,
 
 
2014
 
2013
Numerator
 
 
 
 
Income from continuing operations
 
$
19,644

 
$
19,974

Income from discontinued operations
 

 
2,556

Net income attributable to noncontrolling interests
 
(1,825
)
 
(4,438
)
Net income attributable to the Company
 
17,819

 
18,092

Allocation of earnings to participating securities
 
(128
)
 
(66
)
Numerator for basic and diluted earnings per share—net income attributable to common stockholders
 
$
17,691

 
$
18,026

Denominator
 
 
 
 
Denominator for basic earnings per share—weighted average number of common shares outstanding
 
140,767

 
137,538

Effect of dilutive securities:(1)
 
 
 
 
Share and unit-based compensation plans
 
50

 
78

Denominator for diluted earnings per share—weighted average number of common shares outstanding
 
140,817

 
137,616

Earnings per common share—basic:
 
 
 
 
Income from continuing operations
 
$
0.13

 
$
0.11

Discontinued operations
 

 
0.02

Net income attributable to common stockholders
 
$
0.13

 
$
0.13

Earnings per common share—diluted:
 
 
 
 
Income from continuing operations
 
$
0.13

 
$
0.11

Discontinued operations
 

 
0.02

Net income attributable to common stockholders
 
$
0.13

 
$
0.13

 
 
 
(1)
Diluted EPS excludes 184,304 convertible preferred units for the three months ended March 31, 2014 and 2013 as their impact was antidilutive.
Diluted EPS excludes 10,068 of unexercised stock options for the three months ended March 31, 2014 as their impact was antidilutive.
Diluted EPS excludes 9,991,438 and 10,206,924 Operating Partnership Units ("OP Units") for the three months ended March 31, 2014 and 2013, respectively, as their impact was antidilutive.